Aspargo Laboratories
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
17 State St Ste 3220, New York City, New...Phone Number
(646) 503-1260Website
www.aspargolabs.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Aspargo Laboratories
Aspargo Laboratories Inc. specializes in developing oral suspension formulations of medications, including the erectile dysfunction medication Sildenafil citrate. Their unique suspension technology enhances patient experiences, improves absorption rates, and offers better taste. Aspargo Labs is also pioneering a user-friendly mobile platform and high-tech device for dispensing medication cartridges, providing real-time data for patients, physicians, and caregivers. With global accomplishments such as launching liquid oral sildenafil suspension products in multiple countries, Aspargo Labs continues to set the standard for patient-centric care and innovative pharmaceutical solutions.Explore more
Aspargo Laboratories Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aspargo Laboratories your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aspargo Laboratories had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Aspargo Laboratories recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Aspargo Laboratories launches new products
Congratulate Masked Content for being promoted to Masked Content at Aspargo Laboratories
Funding: Get notified immidiatlly once Aspargo Laboratories has new funding data
Check out if Aspargo Laboratories is spiking on competitors!
Check if Aspargo Laboratories has recently received funding, and reach out quickly before it becomes old news!
Aspargo Laboratories, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Aspargo Laboratories as Masked Content
Find 2 more new buyers
Compare Similar Companies to Aspargo Laboratories
Compare insights from companies similar to Aspargo Laboratories, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aspargo Laboratories is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aspargo Laboratories is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aspargo Laboratories.
Aspargo Laboratories Tech Stack
A closer look at the technologies used by Aspargo Laboratories
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Aspargo Laboratories News & Media
Biotech companies appoint new chief finance heads - BioXconomy
Multiple pharmaceutical firms announced new CFO hires in recent weeks as companies strengthen their financial leadership teamsAspargo Labs Appoints Sam Backenroth as Chief Financial Officer
Adds experienced public-company finance executive to advance Aspargo’s corporate, commercial, and capital markets strategies Adds experienced public-company finance executive to advance Aspargo’s corporate, commercial, and capital markets strategiesAspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a Pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in proprietary digitally connected devices, announced that Michael Demurjian, CEO & Chairman, will participate in a panel discussion at the American Urological Association (AUA) Innovation Nexus Conference in Las Vegas, Nevada, taking place on April 25, 2025.Aspargo Labs Expands Global Leadership Team
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in proprietary digitally connected devices, announced the appointments of Jamel Benkreira as General Manager, United Kingdom & Ireland; and Dr. Pallav S. Shah as Director of Regulatory Affairs, Europe. These strategic appointments strengthen the Comp
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aspargo Laboratories
Sign Up For FreeTo access detailed company insights
Aspargo Laboratories Inc. specializes in developing oral suspension formulations of medications, including the erectile dysfunction medication Sildenafil citrate. Their unique suspension technology enhances patient experiences, improves absorption rates, and offers better taste. Aspargo Labs is also pioneering a user-friendly mobile platform and hi... Read More
